The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis Pain

NACompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

July 12, 2019

Conditions

Osteoarthritis, Knee

Interventions

DEVICE

HYAJOINT Plus

60 mg / 3 ml cross-linked hyaluronan, SciVision Biotech Inc.

DEVICE

Durolane

60 mg / 3 ml cross-linked hyaluronan, Bioventus LLC.

Trial Locations (1)

National Cheng-Kung University Hospital, Tainan City

All Listed Sponsors

lead

SciVision Biotech Inc.

INDUSTRY

NCT04000204 - The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis Pain | Biotech Hunter | Biotech Hunter